Evidence-Based Medicine Should Drive Medical Liability Reform, Project HOPE's Wilensky Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Providing protections to those who follow guidelines should appeal to both Republicans and Democrats, the former McCain campaign advisor says.
You may also be interested in...
Drug Safety Diligence Demands Proactive, Ongoing Assessment – FDLI Panel
To stay afloat with heightened and still-evolving drug safety standards, drug firms must investigate their products for safety signals even in the absence of any indication of a problem, according to a panel at an April 22 conference of the Food & Drug Law Institute
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.